Elisabeth de Vries

Has grant

Professor

Universitair Medisch Centrum Utrecht

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

VOICE: Vaccination against cOvid In CancEr

Open Date: 2021-01-01

Close Date:

Grant: Close

Immune-Image: Specific imaging of immune cell dynamics using novel tracer strategies

Open Date: 2019-10-01

Close Date: 2024-10-01

Grant: Close

Netherlands facility for Cancer-Immune Analysis (N-CIA)

Open Date: 2018-05-01

Close Date:

Grant: Close

POINTING: Towards patients-tailored cancer immunotherapy supported by a multifaceted predictive signature composed of integrative omics and molecular imaging

Open Date: 2017-09-01

Close Date:

Grant: Close

Validation of translational imaging methods in drug safety assessment (TRISTAN)

Open Date: 2017-01-01

Close Date:

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Jourik A. Gietema

NETHERLANDS

View details

Ronald Boellaard

Head imaging methodology

VU medisch centrum

NETHERLANDS

View details

Jorge Barriuso

The University of Manchester

UNITED KINGDOM

View details

Otto S Hoekstra

Prof.

VU medisch centrum

NETHERLANDS

View details

Elena Garralda

SPAIN

View details

A. W. J. M. Glaudemans

University Medical Center Groningen

NETHERLANDS

View details

Hedwig Blommestein

Associate professor

Erasmus University Rotterdam

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Elisabeth de Vries

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Changes in survival in de novo metastatic cancer in an era of new medicines

Meta-Analysis of the Test–Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor Response

[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

Phase II study (KAMELEON) of single‐agent T‐DM1 in patients with HER2‐positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma

Towards evidence-based response criteria for cancer immunotherapy

Methodological and reporting standards for quality of life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit

Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward

Noise sensitivity of 89Zr-Immuno-PET radiomics based on count-reduced clinical images

Towards less mutilating treatments in patients with advanced non-melanoma skin cancers by earlier use of immune checkpoint inhibitors

Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial

Collaborators (7)

Jourik A. Gietema

Ronald Boellaard

Jorge Barriuso

Otto S Hoekstra

Elena Garralda

A. W. J. M. Glaudemans

Hedwig Blommestein

Make your next move.